Human Cord Blood CD34/CD133+ Progenitor Cells
CD34 is a well-known marker for primitive and bone marrow-derived progenitor cells, especially for hematopoietic and endothelial progenitors. CD34+ progenitor cells are suitable for a series of studies for directed differentiation into more committed types of blood cells and endothelial lineages. Immediately after isolation, the freshly prepared CD34+ progenitor cells are cryopreserved using a serum-free freezing medium.
The majority of CD133+ cells also express CD34. Cord blood CD133+ cells are isolated using direct positive immunomagnetic selection for CD133+ cells.
Ace Therapeutics offers CD34+ progenitor cells and CD133 cells in a phenotypically undifferentiated state.
The majority of CD133+ cells also express CD34. Cord blood CD133+ cells are isolated using direct positive immunomagnetic selection for CD133+ cells.
Ace Therapeutics offers CD34+ progenitor cells and CD133 cells in a phenotypically undifferentiated state.
| Supplier | Ace Therapeutics |
|---|---|
| Product # | BBM-C-171 |
| Pricing | Inquiry |
| Product Category | Stem Cells |
| Species | Human |
| Citation Guidance | If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. |
| Source | Human Cord Blood |
| Recommended Medium | It is recommended to use Human Cord Blood CD34/CD133+ Progenitor Cells Medium Kit for culturing in vitro. |
| Cell Type | Stem Cell |
| Disease | Normal |
| Quality Control | Human Cord Blood CD34/CD133+ Progenitor Cells test negative for bacteria, yeast, fungi, and mycoplasma. |
| Shipping and Storage |
|